1
TITLE: Symptomatic skeletal events (SSEs) versus skeletal- related events (SREs) in patients with advanced cancer and bone metastases treated with denosumab or zoledronic acid
AUTHORS: von Moos, R; Costa, LAM; Scagliotti, G; Sleeboom, H; Goldwasser, F; Hirsh, V; Spencer, A; Radcliffe, HS; Niepel, D; Henry, DH;
PUBLISHED: 2016, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 27
INDEXED IN: Scopus WOS
2
TITLE: Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply
AUTHORS: David H Henry; Luis Costa; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLISHED: 2011, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, ISSUE: 19
INDEXED IN: Scopus WOS